Content uploaded by Cora Peterson
Author content
All content in this area was uploaded by Cora Peterson on Apr 19, 2021
Content may be subject to copyright.
Repeat Self-Inflicted Injury Among U.S. Youth in a Large Medical
Claims Database
Cora Peterson, PhD, Likang Xu, MD, Ruth W. Leemis, PhD, and Deborah M. Stone, ScD
National Center for Injury Prevention and Control, Centers for Disease Control and Prevention,
Atlanta, Georgia
Abstract
Introduction: This study describes characteristics of nonfatal self-inflicted injuries and incidence
of repeat self-inflicted injuries among a large convenience sample of youth (aged 10−24 years)
with Medicaid or commercial insurance.
Methods: In 2018, Truven Health MarketScan medical claims data were used to identify youth
with a self-inflicted injury in 2013 (or index self-inflicted injury) diagnosed in any inpatient or
outpatient setting. Patients with 2 years of healthcare claims data (1 year before/after index self-
inflicted injury) were assessed. Patient and injury characteristics, repeat self-inflicted injuries ≤1
year, time to repeat self-inflicted injury, and number of emergency department and urgent care
facility visits per patient are reported. A regression model assessed factors associated with repeat
self-inflicted injuries.
Results: Among 4,681 self-inflicted injury patients, 70% were female. More than 71% of
patients were treated for comorbidities (50% for depression) ≤1 year preceding the index self-
inflicted injury. Poisoning was the most common index self-inflicted injury mechanism (60% of
patients). Approximately 52% of patients had one or more emergency department visit and 1% had
one or more urgent care facility visit, respectively, during the 2-year observation period. More than
11% of patients repeated self-inflicted injury ≤1 year (and 3% ≤7 days). Repeat self-inflicted
injury was associated with younger patient age, being female, a self-inflicted injury event
preceding the index self-inflicted injury, index self-inflicted injury treatment setting, and patient
comorbidities.
Conclusions: Approximately one in ten youth repeated self-inflicted injury within 1 year and
nearly half of youth with clinically treated self-inflicted injuries never received care in hospitals or
emergency departments. Physicians and families should be aware of risk factors for repeat self-
inflicted injury, including mental health comorbidities. Multilevel strategies are needed to prevent
youth self-inflicted injuries.
Address correspondence to: Cora Peterson, PhD, Mailstop F-62, 4770 Buford Hwy., CDC National Center for Injury Prevention and
Control, Atlanta GA 30341. vsm2@cdc.gov.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers
for Disease Control and Prevention.
No financial disclosures were reported by the authors of this paper. No conflicts of interest were reported by the authors of this paper.
SUPPLEMENTAL MATERIAL
Supplemental materials associated with this article can be found in the online version at https://doi.org/10.1016/j.amepre.2018.09.009.
HHS Public Access
Author manuscript
Am J Prev Med
. Author manuscript; available in PMC 2020 March 01.
Published in final edited form as:
Am J Prev Med
. 2019 March ; 56(3): 411–419. doi:10.1016/j.amepre.2018.09.009.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
INTRODUCTION
The U.S. rate of hospital emergency department (ED) visits for nonfatal self-inflicted
injuries (SII; inclusive of suicidal and nonsuicidal intent) among youth aged 10−24 years
increased substantially during 2009−2015.1 Among females aged 10−14 years, ED visits
nearly tripled (from 109.8 to 317.7 per 100,000 people).1 Data from the United Kingdom
and Canada also indicate substantial increases in hospital-based (ED or inpatient) SII
treatment among females aged less than 18 years over the same period.2,3 Only one in ten
youth with SII receive hospital-based treatment, suggesting just a small portion of affected
youth are identified in the hospital data used to document these recent increases.4,5 Large
U.S. school-based convenience sample surveys have estimated the lifetime prevalence of
youth nonfatal self-injurious behavior is 8% of third graders,6 4%6 to 8% (past-year
prevalence)7 of sixth to eighth graders, 13%6 to 16%8 of ninth to twelfth graders, and 15%9
to 17%10 of college students.
A majority of youth who self-injure do so multiple times,10–13 and people who self-injure
are at substantially greater risk of suicide.9,14–16 Most longitudinal research on healthcare
contacts—including repeat injury—among youth with SII comes from non−U.S. ED
registries. A recent systematic review of studies worldwide over the preceding 30 years
reported the average 1-year incidence of repeat SII was 16% (
n
=78 studies) and fatal self-
harm was 2% (
n
=40 studies) among patients of all ages initially treated for SII in hospital
settings.17 There were just three U.S. studies in that systematic review; the most recent used
data from 1980, and none focused on youth.18–20
Large U.S. medical claims databases offer an opportunity to investigate healthcare contacts
over time among youth with SII in all clinical settings (i.e., not limited to hospitals). The aim
of this study is to describe characteristics of SII and repeat SII incidence within 1 year
among a large nationwide convenience sample of U.S. youth with Medicaid or commercial
insurance.
METHODS
Study Sample
This study used publicly available data and no human subjects. In 2018, authors used Truven
Health MarketScan data for patients aged 10−24 years with commercial or Medicaid
insurance and identified the first date of an inpatient or outpatient medical claim with an SII
diagnosis in 2013 (or index SII) for this analysis. MarketScan includes paid insurance claims
and encounters from participating large employers, MCOs, hospitals, electronic medical
record providers, and some Medicare and Medicaid contributors.21 MarketScan is not
representative of the U.S. population. In 2013, 62% of the U.S. population had private health
insurance (e.g., employer), 18% had Medicaid, and 17% were uninsured.22 MarketScan does
not report mortality; therefore, it was not possible to assess fatal self-harm.
Measures
SII was defined by ICD-9-CM external cause codes (E-codes) E950–9 (i.e., suicide and SII;
or SII diagnosis). Transition to ICD-10-CM diagnosis coding took place in October 2015, or
Peterson et al. Page 2
Am J Prev Med
. Author manuscript; available in PMC 2020 March 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
the end of the period (2009−2015) during which a substantial increase in ED visits for youth
SII has been documented.1 Coding consistency for this study’s full observation period
guided authors’ decision to use year 2013 index injury data and 2014 as a follow-up period.
E-codes are not explicitly used for payment, and not all injury medical claims include E-
codes; however, E-codes are the only way to identify injury intent (i.e., self-harm) using
ICD-9-CM diagnoses.
Investigation of subsequent SII required that authors designate an index event to begin
observation. Given the nature of administrative medical data, it was not possible to ensure
that this was patients’ first-ever SII event. To ensure that each patient’s first 2013 SII record
(i.e., index SII) was a new event (and not continued treatment from a previous SII event),
authors excluded patients who were existing inpatients on January 1, 2013, and patients with
an index SII date before January 30, 2013, who were treated for the same injury mechanism
(e.g., self-inflicted poisoning) in a non-ED or urgent care facility (UCF) setting within the
previous 30 days. Patients with 12 months of continuous insurance enrollment before and
after the index SII date (i.e., spanning different parts of 2012−2014 per patient, depending
on the 2013 index SII date) comprised the analysis sample (Figure 1).
Patient sex, age at index SII, comorbidities (e.g., depression), insurance payer type
(Medicaid or commercial), all clinical settings (i.e., clinician office, ambulance, UCF, ED,
inpatient) where the patient was treated on the day the index SII was diagnosed (or initial
treatment), index SII mechanism, preceding SII within 1 year before the index SII, and
repeat SII within 1 year after index SII were assessed using source data. Comorbidities were
identified by ICD-9-CM diagnosis codes (as defined in the Agency for Healthcare Research
and Quality’s Elixhauser Comorbidity Index, Version 3.7) in each patient’s inpatient and
outpatient medical claims within 1 year preceding and including the patient’s index SII date.
Clinical treatment settings were identified by service place (e.g., UCF) and service category
(e.g., ED-related) information reported in the data source. Some patients were treated in
multiple clinical settings on the index SII date (e.g., ambulance and ED). Inpatient treatment
on the day following the index SII diagnosis date was assessed as initial index SII treatment.
Injury mechanism was defined by standard E-code classifications.23 E-codes with specified
mechanism (e.g., E955.0 “Suicide and self-inflicted injury by handgun”) were prioritized
over unspecified mechanism (e.g., E958.9, “Suicide and self-inflicted injury by unspecified
means”) if a patient had multiple different SII diagnosis codes on the index SII date.
Medical claims do not typically include explicit distinction between initial events and
follow-up care. This study’s analysis of index and subsequent SII therefore required
definitions using administrative codes (e.g., diagnosis) to identify repeat SII (i.e., a new SII
event). Repeat SII within 1 year of the index SII was defined as a medical claim for:
1. UCF or ED services with any SII diagnosis on any date after the index SII date;
or
2. treatment in any other clinical setting (i.e., neither an ED nor UCF) for the same
SII mechanism as the index SII (i.e., a claim including any of the same E950–9
codes) occurring ≥30 days after the index SII; or
Peterson et al. Page 3
Am J Prev Med
. Author manuscript; available in PMC 2020 March 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
3. treatment in any clinical setting on any date after the index SII date for a
different SII mechanism than the index SII (i.e., a claim with none of the same
E950–9 codes).
Authors used the same method in reverse to identify patients with an SII within 1 year
preceding the index SII.
Statistical Analysis
Authors used SAS, version 9.4 for analysis. Descriptive data are presented on patient and
injury characteristics by age group (10−14 years, 15−19 years, 20−24 years), including
number and proportion of patients by sex, type of comorbidities (those affecting >5% of
total patients are reported individually), insurance payer type, index SII initial clinical
treatment setting, index SII mechanism, and preceding SII and repeat SII (i.e., relative to the
index SII). Chi-square tests compared the proportion of patients in each of the two older age
groups to the youngest age group for each of these factors. A logistic regression model
assessed whether these factors were associated with repeat SII within 1 year. Authors
separately report the number and proportion of patients with first repeat SII by index SII
mechanism. For statistical reliability, SII mechanism sample sizes of <21 patients were not
assessed for repeat SII incidence. A Kaplan−Meier plot demonstrates time from index SII
date to first repeat SII. Authors also report the number of SII ED and UCF visits (defined by
a medical claim for any SII diagnosis in an ED or UCF) during the entire observation period
per patient (or 2 years; within 1 year before/after the index SII). The ED/UCF analysis
aimed to provide insight into the proportion of youth SII patients in this sample that had
clinical treatment entirely outside of ED/UCF settings; this information can contextualize
data on the prevalence of U.S. youth SII ED visits.1
RESULTS
Among 4,681 youth SII patients (2,818 with commercial insurance and 1,863 with
Medicaid; Figure 1), 70% were female (Table 1). More than 71% of patients were diagnosed
with comorbidities within 1 year preceding the index SII date (Table 1). The most prevalent
diagnosed comorbidities among all patients were depression (49% of patients), psychosis
(24%), drug abuse (19%), chronic pulmonary disease (16%; the Elixhauser comorbidity
classification includes asthma in this category), neurologic disorders (12%), and alcohol
abuse (9%; Table 1). Patients aged 20−24 years had the highest prevalence of any
comorbidity (79%; Table 1). That higher prevalence was due to all afore-mentioned
comorbidity types except chronic pulmonary disease (similar prevalence among all age
groups; Table 1).
Nearly 10% of patients were treated in a clinician office, 16% in an ambulance, 1% in a
UCF, 50% in an ED, and 48% as inpatients on the day that their index SII was diagnosed
(Table 1). Poisoning was the most prevalent single index SII mechanism among all age
groups (60% of patients), followed by cut/pierce injuries (24%; Table 1). Three percent of
total patients had a preceding SII within 1 year before the index SII (Table 1). More than
60% of patients had commercial insurance, reflecting the higher prevalence of commercial
insurance patients in the data source (Table 1).
Peterson et al. Page 4
Am J Prev Med
. Author manuscript; available in PMC 2020 March 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Compared with the older two age groups, a significantly lower proportion of patients in the
group aged 10−14 years had commercial insurance (53%), diagnosed comorbidities (61%),
initial index SII treatment in an ambulance (13%) or as inpatients (45%; significantly
different from age 20−24 years patients), and poisoning index SII mechanism (50%; Table
1). A significantly higher proportion of patients aged 10−14 years had index SII initial
clinical treatment in clinician offices (14%), and cut/pierce (29%), suffocation (3%), or
unspecified (8%; significantly different from age 15−19 years) index SII mechanism (Table
1).
More than 11% (
n
=527/4,681) of patients repeated SII within 1 year of the index SII (Table
1). Lower age (OR=0.96, 95% CI=0.93, 0.99), being female (OR=1.61, 95% CI=1.28, 2.03),
prior diagnosis of depression (OR=1.58, 95% CI=1.29, 1.92), psychoses (OR=1.33, 95%
CI=1.06, 1.65), chronic pulmonary disease (OR=1.37, 95% CI=1.08, 1.73), index SII
inpatient initial treatment (OR=0.71, 95% CI=0.54, 0.95), and SII event in the year
preceding the index SII (OR=1.65, 95% CI=1.08, 2.53) were associated with repeat SII
within 1 year (Table 1).
Repeat SII rates ranged from 3% of patients with multiple index SII mechanisms to 13% of
patients with cut/ pierce index SII mechanism (Table 2). Most sample sizes were too small to
assess repeat SII by injury mechanism (i.e., same/different compared with index SII),
although a far lower proportion of patients with index SII poisoning (30%,
n
=91/304)
compared with cut/pierce (60%,
n
=87/145) used the same mechanism at the first repeat SII
event (Table 2). First repeat SII occurred throughout the 1-year follow-up observation period
for all age groups (Figure 2). At ≤7 days, 8−30 days, and 31−180 days since index SII, 3%
(
n
=126/4,681), 1% (
n
=50/4,681), and 5% (
n
=216/4,681) of patients had medical treatment
for a repeat SII event (Figure 2), respectively.
Just 52% of patients (
n
=2,443/4,681) with clinically treated SII had one or more SII ED
visits during the total 2-year observation period per patient and 5% (
n
=239/ 4,681) of
patients had two or more SII ED visits (Appendix Figure 1, available online). Less than 1%
of patients (
n
=33/4,681) had one or more SII UCF visits (Appendix Figure 1, available
online).
DISCUSSION
Retrospective analysis of U.S. medical claims data allowed this study to make three data
contributions that may ultimately inform clinical and public health activities related to youth
SII. First, this study appears to be the first large-sample assessment of repeat SII in the U.S.
in decades, and the first to focus on youth SII.15,17 This study reported the incidence of
repeat SII within 1 year among youth with clinically diagnosed SII (11%) and reported that
several observable factors in medical claims data (patient age, sex, comorbidities, preceding
SII event, and index SII initial treatment setting) were associated with repeat SII.
Second, this study assessed the prevalence of clinically diagnosed comorbid conditions
among youth SII patients, identifying that more than 70% of patients were diagnosed or
treated for comorbidities within 1 year preceding the index SII. In other words, a majority of
Peterson et al. Page 5
Am J Prev Med
. Author manuscript; available in PMC 2020 March 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
patients in this sample had underlying health conditions and contact with clinicians
regarding those conditions shortly before SII. Third, this study’s finding that only half of
youth with clinically diagnosed SII were treated in an ED suggests a large proportion of
youth with clinically diagnosed SII (i.e., only a subset of all youth with SII) are not
identified in ED-based data.
This analysis estimated that among youth SII patients, younger age; being female; previous
diagnosis of depression, psychosis, or chronic pulmonary disease (including asthma); and
preceding SII event were associated with a higher likelihood of repeat SII within 1 year, and
that inpatient treatment for index SII was associated with lower risk of repeat SII. The
finding of increased risk for repeat SII among patients with mental health comorbidities is
consistent with previous research reporting that long-standing psychosocial vulnerabilities
are associated risk factors for repeat self-harm injury.11 The finding of increased risk
associated with a preceding SII event appears consistent with previous research indicating
that some SII patients are chronically and severely affected.12,24 The significant association
between chronic pulmonary disease (including asthma) and repeat SII merits further
investigation. The association of index SII inpatient treatment with reduced likelihood of
repeat SII might indicate successful treatment following a severe self-harm event. This result
merits further investigation.
This study’s finding of 11% repeat SII within 1 year is slightly lower than the average 16%
reported in a previous systematic review of (primarily non−U.S.) studies.17 Unlike most
studies in that review, which assessed only hospital-treated index SII and repeat SII, this
study assessed index SII and repeat SII diagnosed in any clinical setting.8 One might assume
that observing all clinical settings for repeat SII could incline the present study toward a
higher repeat SII rate than the 16% observed in hospital-only studies (i.e., by capturing
patients’ non-hospital clinical care). On the other hand, by observing all clinical settings for
an index SII diagnosis, the present study might have included patients with less severe index
SII than hospital-based studies (and perhaps less likely to repeat), resulting in a lower overall
rate of repeat SII compared with hospital-based studies. Another difference is that the
present study assessed only insured patients. Previous research using ED visit data likely
captured non-insured patients who potentially have additional risk factors for repeat SII.1
A logical next research goal would be to use U.S. medical claims or similar data to assess
how many youth SII patients received appropriate treatment. However, evidence to guide
clinical management of self-harm is sparse, rendering it difficult to define “appropriate
treatment” for such a future study.25,26 A recent systematic review and meta-analysis of SII
interventions among children and youth concluded that the evidence base is extremely
limited, although therapeutic assessment, mentalization therapy, and dialectical behavior
therapy merit further evaluation.26
Because there is no one single biological or psychosocial determinant of self-harm,
comprehensive prevention strategies that address a range of factors, in a range of settings
(e.g., school, community, healthcare) are needed. The Centers for Disease Control and
Prevention’s technical package to prevent suicide helps states and communities identify
strategies with the best available evidence. These strategies include teaching coping and
Peterson et al. Page 6
Am J Prev Med
. Author manuscript; available in PMC 2020 March 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
problem-solving skills and promoting connectedness, identifying and supporting people
already at risk, and creating protective environments and strengthening access and delivery
of suicide care to prevent future risk.27
LIMITATIONS
This study has at least four notable limitations. First, a major limitation is the lack of
mortality information. As previously noted, a systematic review reported an average 2% of
patients died by suicide within 1 year of hospital-treated SII.17 Second, this study’s
MarketScan data source lacked comprehensive data on patients’ socioeconomic and race/
ethnicity information. For example, previous research has reported a high proportion of
patients hospitalized following a suicide attempt are white males and that SII mechanism is
associated with patient race/ethnicity.28 Third, this study relied on administrative coding,
which implies a number of limitations. Authors were limited to E-codes to identify self-
harm intent on medical claims for injury treatment, and proposed criteria to use available
administrative data (e.g., clinical setting, injury mechanism) to differentiate unique SII
events. Authors’ use of administrative data also did not facilitate investigation of a wide
range of risk factors for repeat SII that have been investigated in survey studies, such as
patients’ familial relationships.7
The fourth limitation is that this study’s 1-year follow-up period to observe repeat SII is
shorter than previous studies using hospital-based registry data in other countries. For
example, over a 7-year study period, 22% of SII patients presented on at least two occasions
to EDs in Ireland, 10% presented at least three times, and 1% presented at least ten times.12
However, nearly half of those observed repeat injuries occurred within 3 months of the index
SII and almost two thirds occurred within 6 months, suggesting that the 1-year observation
period employed in this study may capture the majority of patients that repeat SII.12
CONCLUSIONS
This study described SII and repeat SII among a large sample of U.S. youth during a period
in which prevalence of youth SII increased substantially, according to population-based ED
visit data in the U.S. and other countries. This study reported that just half of youth with
clinically treated SII were seen in an ED and that 11% of patients sought clinical treatment
for repeat SII within 1 year. Notably, 70% of youth with clinically treated SII were seen by a
clinician for comorbidities in the 12 months prior to SII treatment. Such information on
health care provider contacts with youth patients at risk of SII may be used to target
prevention and treatment activities. Beyond identifying at-risk patients, clinical and public
health decision making will benefit from widespread implementation of evidence-based
primary prevention strategies, further implementation of proven approaches, and
identification of new strategies for SII, that, together, will ultimately help to prevent suicide.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Peterson et al. Page 7
Am J Prev Med
. Author manuscript; available in PMC 2020 March 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
ACKNOWLEDGMENTS
Cora Peterson conceived of the study, led the study design and interpretation of results, assisted with data analysis,
and drafted and edited the manuscript for important intellectual content. Likang Xu assisted with the study design
and interpretation of results, led data analysis, and edited the manuscript for important intellectual content. Ruth W.
Leemis assisted with the study design and interpretation of results, and edited the manuscript for important
intellectual content. Deborah M. Stone assisted with the study design and interpretation of results, and edited the
manuscript for important intellectual content. All authors approved the final manuscript as submitted.
REFERENCES
1. Mercado MC, Holland K, Leemis RW, Stone DM, Wang J. Trends in emergency department visits
for nonfatal self-inflicted injuries among youth aged 10 to 24 years in the United States,
2001−2015. JAMA 2017;318(19):1931–1933. 10.1001/jama.2017.13317. [PubMed: 29164246]
2. Campbell D NHS figures show ‘shocking’ rise in self-harm among young The Guardian
www.theguardian.com/society/2016/oct/23/nhs-figures-show-shocking-rise-self-harm-young-
people. Published October 23, 2016. Accessed September 13, 2018.
3. Canadian Institute for Health Information. Intentional Self-Harm Among Youth in Canada Ottawa,
Canada: Canadian Institute for Health Information, 2014.
4. Geulayov G, Casey D, McDonald KC, et al. Incidence of suicide, hospital-presenting non-fatal self-
harm, and community-occurring non-fatal self-harm in adolescents in England (the iceberg model of
self-harm): a retrospective study. Lancet Psychiatry 2017;5(2):167–174. 10.1016/
S2215-0366(17)30478-9. [PubMed: 29246453]
5. Madge N, Hewitt A, Hawton K, et al. Deliberate self-harm within an international community
sample of young people: comparative findings from the Child & Adolescent Self-harm in Europe
(CASE) Study. J Child Psychol Psychiatry 2008;49(6):667–677. 10.1111/j.
1469-7610.2008.01879.x. [PubMed: 18341543]
6. Barrocas AL, Hankin BL, Young JF, Abela JR. Rates of nonsuicidal self-injury in youth: age, sex,
and behavioral methods in a community sample. Pediatrics 2012;130(1):39–45. 10.1542/peds.
2011-2094. [PubMed: 22689875]
7. Hilt LM, Nock MK, Lloyd-Richardson EE, Prinstein MJ. Longitudinal study of nonsuicidal self-
injury among young adolescents. J Early Adolescence 2008;28(3):455–469.
10.1177/0272431608316604.
8. Muehlenkamp JJ, Gutierrez PM. An investigation of differences between self-injurious behavior and
suicide attempts in a sample of adolescents. Suicide Life Threat Behav 2004;34(1):12–23.
[PubMed: 15106884]
9. Whitlock J, Muehlenkamp J, Purington A, et al. Nonsuicidal self-injury in a college population:
general trends and sex differences. J Am Coll Health 2011;59(8):691–698.
10.1080/07448481.2010.529626. [PubMed: 21950249]
10. Whitlock J, Eckenrode J, Silverman D. Self-injurious behaviors in a college population. Pediatrics
2006;117(6):1939–1948. 10.1542/peds.2005-2543. [PubMed: 16740834]
11. Larkin C, Di Blasi Z, Arensman E. Risk factors for repetition of self-harm: a systematic review of
prospective hospital-based studies. PLoS ONE 2014;9(1):e84282 10.1371/journal.pone.0084282.
[PubMed: 24465400]
12. Perry IJ, Corcoran P, Fitzgerald AP, Keeley HS, Reulbach U, Arensman E. The incidence and
repetition of hospital-treated deliberate self harm: findings from the world’s first national registry.
PLoS ONE 2012;7(2):e31663 10.1371/journal.pone.0031663. [PubMed: 22363700]
13. Bennardi M, McMahon E, Corcoran P, Griffin E, Arensman E. Risk of repeated self-harm and
associated factors in children, adolescents and young adults. BMC Psychiatry 2016;16:421
10.1186/s12888-016-1120-2. [PubMed: 27881107]
14. Bergen H, Hawton K, Waters K, et al. How do methods of non-fatal self-harm relate to eventual
suicide? J Affect Disord 2012;136(3):526–533. 10.1016/j.jad.2011.10.036. [PubMed: 22127391]
15. Owens D, Horrocks J, House A. Fatal and non-fatal repetition of self-harm: systematic review. Br J
Psychiatry 2002;181:193–199. 10.1192/bjp.181.3.193. [PubMed: 12204922]
Peterson et al. Page 8
Am J Prev Med
. Author manuscript; available in PMC 2020 March 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
16. Mars B, Heron J, Crane C, et al. Clinical and social outcomes of adolescent self harm: population
based birth cohort study. BMJ 2014;349: g5954 10.1136/bmj.g5954. [PubMed: 25335825]
17. Hawton K, Bergen H, Kapur N, et al. Repetition of self-harm and suicide following self-harm in
children and adolescents: findings from the Multicentre Study of Self-harm in England. J Child
Psychol Psychiatry 2012;53(12):1212–1219. 10.1111/j.1469-7610.2012.02559.x. [PubMed:
22537181]
18. Carroll R, Metcalfe C, Gunnell D. Hospital presenting self-harm and risk of fatal and non-fatal
repetition: systematic review and meta-analysis. PLoS ONE 2014;9(2):e89944 10.1371/
journal.pone.0089944. [PubMed: 24587141]
19. McFarland BH, Beavers DJ. Psychiatric consultation following attempted suicide. J Am Osteopath
Assoc 1986;86(11):743–750. [PubMed: 3793538]
20. Pederson AM, Awad GA, Kindler AR. Epidemiological differences between white and nonwhite
suicide attempters. Am J Psychiatry 1973;130(10):1071–1076. 10.1176/ajp.130.10.1071.
[PubMed: 4728898]
21. Steer RA, Beck AT, Garrison B, Lester D. Eventual suicide in interrupted and uninterrupted
attempters: a challenge to the cry-for-help hypothesis. Suicide Life Threat Behav 1988;18(2):119–
128. 10.1111/j.1943-278X.1988.tb00146.x. [PubMed: 3420640]
22. Hansen L The Truven Health MarketScan Databases for life sciences researchers: white paper Ann
Arbor, MI: Truven Health Analytics, 2017.
23. Cohen RA. Long-term trends in health insurance: estimates from the National Health Interview
Survey, United States, 1968−2016 Atlanta, GA: National Center for Health Statistics, 2017.
24. CDC. Tools for Categorizing Injuries using ICD Codes, External Cause-of-Injury (E-code)
Matrices, ICD-9. 2017 www.cdc.gov/nchs/injury/injury_tools.htm. Updated January 26, 2017.
Accessed December 11, 2017.
25. Ness J, Hawton K, Bergen H, et al. High-volume repeaters of self-harm. Crisis 2016;37(6):427–
437. 10.1027/0227-5910/a000428. [PubMed: 27733063]
26. Kapur N, Steeg S, Webb R, et al. Does clinical management improve outcomes following self-
harm? Results from the Multicentre Study of Self-Harm in England. PLoS ONE 2013;8(8):e70434
10.1371/journal.pone.0070434. [PubMed: 23936430]
27. Hawton K, Witt KG, Taylor Salisbury TL, et al. Interventions for self-harm in children and
adolescents. Cochrane Database Syst Rev 2015; (12):CD012013 10.1002/14651858.CD012013.
[PubMed: 26688129]
28. Stone DM, Holland KM, Bartholow BN, Crosby AE, Jack SPD, Wilkins N. Preventing Suicide: A
Technical Package of Policies, Programs, and Practices Atlanta, GA: National Center for Injury
Prevention and Control, CDC, 2017.
29. Hanuscin C, Zahmatkesh G, Shirazi A, Pan D, Teklehaimanot S, Bazargan-Hejazi S. Socio-
demographic and mental health profile of admitted cases of self-inflicted harm in the U.S.
population. Int J Environ Res Public Health 2018;15(1):77 10.3390/ijerph15010077.
Peterson et al. Page 9
Am J Prev Med
. Author manuscript; available in PMC 2020 March 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Figure 1.
Sample selection.
aAges 10−24 years in 2013 determined by year of birth 1989−2004 for Medicaid enrollees.
bNon-fatal self-inflicted injury (SII) defined by ICD-9-CM codes E950−959 (suicide and
self-inflicted injury). Patient age defined by date of service.
cIndex SII diagnosis date (date, month, year) defined as the first inpatient or outpatient
diagnosis of non-fatal self-inflicted injury in calendar year 2013.
dEnrollment identified in months in the source dataset (e.g., a patient with an index SII
diagnosis on any date in September 2013 [i.e., calendar month 9] was included in the
analysis sample if the patient was enrolled continuously through 2014 month 9 and
including 2012 month 9).
Peterson et al. Page 10
Am J Prev Med
. Author manuscript; available in PMC 2020 March 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Figure 2.
Time to repeat injury within 1 year after index injury (
n
=527/4,681 patients with repeat
injury).
Peterson et al. Page 11
Am J Prev Med
. Author manuscript; available in PMC 2020 March 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Peterson et al. Page 12
Table 1.
Patient and Injury Characteristics
Measure Summary statistics Regression model, repeat injury ≤1
year of index SII, AOR (95% CI)
(N=4,681)Measure Age 10−14 years
(n=1,006) Age 15−19 years
(n=2,629) Age 20−24 years
(n=1,046) All (N=4,681)
Patient
Age at index SII diagnosis (2013), years, mean (SE) 13.2 (0.03) 16.6 (0.03) 21.7 (0.04) 17.0 (0.05) 0.96 (0.93, 0.99)
a
Sex, female,
n
(%) patients 788 (78.3) 1,859 (70.7) 642 (61.4) 3,289 (70.3) 1.61 (1.28, 2.03)
Comorbidities
b
(2012 − 2013),
n
(%) patients
Any comorbidity 613 (60.9) 1,886 (71.7) 828 (79.2) 3,327 (71.1) NA
Depression 439 (43.6) 1,321 (50.2) 553 (52.9) 2,313 (49.4) 1.58 (1.29, 1.92)
Psychoses 159 (15.8) 583 (22.2) 366 (35.0) 1,108 (23.7) 1.33 (1.06, 1.65)
Drug abuse 67 (6.7) 506 (19.2) 334 (31.9) 907 (19.4) 1.20 (0.93, 1.54)
Chronic pulmonary disease 152 (15.1) 416 (15.8) 163 (15.6) 731 (15.6) 1.37 (1.08, 1.73)
Other neurological disorders 94 (9.3) 287 (10.9) 185 (17.7) 566 (12.1) 1.28 (0.98, 1.68)
Alcohol abuse 16 (1.6) 196 (7.5) 220 (21.0) 432 (9.2) 1.00 (0.71, 1.40)
Other 114 (11.3) 419 (15.9) 360 (34.4) 893 (19.1) 1.03 (0.79, 1.34)
Insurance payer type,
n
(%) patients
Commercial 534 (53.1) 1,527 (58.1) 757 (72.4) 2,818 (60.2) ref
Medicaid 472 (46.9) 1,102 (41.9) 289 (27.6) 1,863 (39.8) 1.10 (0.91, 1.33)
Index SII (2013),
n
(%) patients
Initial clinical treatment setting
Emergency department 484 (48.1) 1,347 (51.2) 497 (47.5) 2,328 (49.7) 0.93 (0.71, 1.22)
Inpatient 451 (44.8) 1,255 (47.7) 556 (53.2) 2,262 (48.3) 0.71 (0.54, 0.95)
Ambulance 132 (13.1) 421 (16.0) 190 (18.2) 743 (15.9) 1.26 (0.98, 1.61)
Clinician office 145 (14.4) 233 (8.9) 83 (7.9) 461 (9.8) 1.10 (0.78, 1.54)
Urgent care facility 7 (0.7) 16 (0.6) 6 (0.6) 29 (0.6) 0.66 (0.15, 2.86)
Other
c
232 (23.1) 666 (25.3) 264 (25.2) 1,162 (24.8) NA
Injury mechanism
d
Poisoning 508 (50.5) 1,639 (62.3) 651 (62.2) 2,798 (59.8) 0.92 (0.61, 1.39)
Cut/pierce 292 (29.0) 584 (22.2) 223 (21.3) 1,099 (23.5) 1.04 (0.68, 1.60)
Am J Prev Med
. Author manuscript; available in PMC 2020 March 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Peterson et al. Page 13
Measure Summary statistics Regression model, repeat injury ≤1
year of index SII, AOR (95% CI)
(N=4,681)Measure Age 10−14 years
(n=1,006) Age 15−19 years
(n=2,629) Age 20−24 years
(n=1,046) All (N=4,681)
Suffocation 33 (3.3) 49 (1.9) 16 (1.5) 98 (2.1) 0.91 (0.42, 1.98)
Motor vehicle 7 (0.7) 11 (0.4) 6 (0.6) 24 (0.5) 1.01 (0.22, 4.55)
Falls 9 (0.9) 6 (0.2) 4 (0.4) 19 (0.4) 0.85 (0.18, 3.95)
Firearms 0 (0) 8 (0.3) 7 (0.7) 15 (0.3) 2.84 (0.60, 13.52)
Fire/flame 0 (0) 6 (0.2) 5 (0.5) 11 (0.2)
e
Drowning/submersion 1 (0.1) 0 (0) 3 (0.3) 4 (0.1)
e
Natural/environmental 3 (0.3) 0 (0.0) 1 (0.1) 4 (0.1)
e
Hot object/substance 1 (0.1) 2 (0.1) 0 (0) 3 (0.1)
e
Multiple mechanism 6 (0.6) 20 (0.8) 5 (0.5) 31 (0.7) 0.28 (0.04, 2.13)
Other specified, classifiable 4 (0.4) 11 (0.4) 1 (0.1) 16 (0.3) 0.76 (0.22, 2.68)
Other specified, not elsewhere classifiable 67 (6.7) 168 (6.4) 56 (5.4) 291 (6.2) 0.84 (0.48, 1.48)
Unspecified 75 (7.5) 125 (4.8) 68 (6.5) 268 (5.7) ref
Multiple non-fatal self-inflicted injuries
Preceding injury ≤1 year of index SII (2012−2013),
n
(%) 20 (2.0) 88 (3.3) 34 (3.3) 142 (3.0) 1.65 (1.08, 2.53)
Follow-up injury ≤1 year of index SII (2013−2014),
n
(%) 129 (12.8) 287 (10.9) 111 (10.6) 527 (11.3) NA
Note:
Boldface indicates statistical significance (
p
<0.05). Bold text in summary statistics columns refers to comparisons of Age 15−19 years group or Age 20−24 years group to Age 10−14 years group; x2
test conducted for rows with total sample size ≥21. Bold text in regression model column indicates variable was significantly associated with subsequent SII in the regression model.
a
Age assessed as continuous variable.
b
Patients could each have ≥1 comorbidities. Other includes comorbidities affecting <5% of patients: obesity, hypertension, fluid and electrolyte disorders, weight loss, deficiency anemias, diabetes, valvular
disease, coagulopathy, rheumatoid arthritis, paralysis, congestive heart failure, liver disease, hypothyroidism, renal failure, chronic blood loss anemia, lymphoma, peripheral vascular disease, solid tumor
without metastasis, pulmonary circulation disease, metastatic cancer, AIDS.
c
Includes non-emergency department hospital outpatient, rural health clinic, federally qualified health center, school, patient home, and others.
d
Injury mechanism definitions: all injury (E950−E959), cut/pierce (E956), drowning/submersion (E954), fall (E957), fire/burn (E958.1, E958.2, E958.7), fire/flame (E958.1), hot object/substance (E958.2,
E948.7), firearm (E955.0−.4), motor vehicle traffic (E958.5), transport, other (E958.6), natural/environmental (E958.3), poisoning (E950−E952), suffocation (E953), other (other specified and classifiable
(E955.5, E955.6, E955.7, E955.9, E958.0, E958.4); other specified, not elsewhere classifiable (E958.8, E959), and unspecified (E958.9)). Reproduced from www.cdc.gov/injury/wisqars/ecode_matrix.html
(Accessed February 17, 2017).
e
Due to small sample sizes of patients with index SII mechanism drowning/submersion, fire/flame, hot object/substance, and natural/environmental, these patients were grouped with mechanism “other
specified, classifiable” for the regression analysis.
NA, not assessed; SII, non-fatal self-inflicted injury.
Am J Prev Med
. Author manuscript; available in PMC 2020 March 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Peterson et al. Page 14
Table 2.
Number and Proportion of Patients With Repeat Injury Within 1 Year by Mechanism
Index SII mechanismaIndex SII, n patients (N=4,681) Repeat SII, n (%)b (N=527) Same mechanism as index, n (%)cDifferent mechanism as index, n (%)c
Poisoning 2,798 304 (10.9) 91 (29.9) 213 (70.1)
Cut/pierce 1,099 145 (13.2) 87 (60.0) 58 (40.0)
Suffocation 98 10 (10.2) NA NA
Motor vehicles 24 2 (8.3) NA NA
Falls 19 NA NA NA
Firearms 15 NA NA NA
Fire/flame 11 NA NA NA
Drowning/submersion 4 NA NA NA
Natural/environmental 4 NA NA NA
Hot object/substance 3 NA NA NA
Multiple mechanism 31 1 (3.2) NA NA
Other specified, classifiable 16 NA NA NA
Other specified, not elsewhere classifiable 291 26 (8.9) 13 (50.0) 13 (50.0)
Unspecified 268 32 (11.9) 12 (37.5) 20 (62.5)
a
Categories for index SII mechanism drowning/submersion, hot object/substance, and natural/environmental not included here due to small sample size.
b
Percent of patients with index SII mechanism, or Column 2.
c
Percent of patients with same/different repeat SII mechanism, or Column 3.
NA, not assessed (due to sample size <21); SII, non-fatal self-inflicted injury.
Am J Prev Med
. Author manuscript; available in PMC 2020 March 01.